Table 2.

Association between autotaxin and cardiometabolic risk factors at baseline

	All		Men		Women
Number of participants	69		20		49
	r	P	r	P	r	P
Age	‐0.11	0.26	‐0.10	0.59	0.03	0.80
Body weight	‐0.08	0.43	0.34	0.06	0.21	0.08
BMI	0.23	0.02	0.46	0.01	0.35	0.003
Fat percent	0.27	0.01	0.34	0.06	0.05	0.68
Fat mass	0.12	0.24	0.38	0.03	0.18	0.14
Fat‐free mass	‐0.22	0.03	0.03	0.87	0.25	0.04
Apo B	0.03	0.74	‐0.05	0.78	0.06	0.64
LDL‐C	0.03	0.77	‐0.11	0.56	0.02	0.85
HDL‐C	0.10	0.30	‐0.06	0.76	‐0.02	0.86
Triglycerides	‐0.02	0.81	‐0.18	0.32	0.18	0.13
Insulin	0.24	0.01	0.67	<.0001	0.35	0.003
Glucose	0.18	0.08	0.11	0.55	0.31	0.01
HbA1c	0.03	0.76	0.26	0.15	0.17	0.16
HOMA‐IR	0.27	0.01	0.59	0.0004	0.37	0.002
Adiponectin	0.04	0.71	0.18	0.36	‐0.01	0.95
Leptin	0.38	0.0002	0.52	0.01	0.06	0.62

LDL: low‐density lipoprotein, HDL: high‐density lipoprotein, HOMA‐IR: homeostatic model of insulin resistance, HbA1c: glycated hemoglobin.

P‐values indicate statistically significant correlations (P < 0.05) in bold.